2022 / 03

Next Paper
DOI: 10.24075/brsmu.2022.025

ORIGINAL RESEARCH

Altered amino acid profiles of the “mother–fetus” system in COVID-19

Lomova NA, Chagovets VV, Dolgopolova EL, Novoselova AV, Petrova UL, Shmakov RG, Frankevich VE
About authors

Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Moscow, Russia

Correspondence should be addressed: Natalia A. Lomova
Oparina, 4, Moscow, 117997, Russia; ur.xednay@avomol-ahsatan

About paper

Funding: the study was funded by the Russian Foundation for Basic Research, grant reg. number 2004-60093.

Author contribution: Lomova NA — clinical data management, manuscript writing; Chagovets VV —mass spectrometry assay, statistical analysis of the data, manuscript editing; Dolgopolova EL — collection and processing of clinical samples in “red zone”, statistical analysis of the data; Novoselova AV — mass spectrometry assay, processing of spectral data; Petrova UL — collection and processing of clinical samples in “red zone”; Shmakov RG — clinical sample collection and data management, manuscript editing; Frankevich VE — concept, data management, writing and editing of the manuscript.

Compliance with ethical standards: the study was approved by Ethical Review Board at the V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology (protocol № 13 of 10 December 2020) and carried out in compliance with Declaration of Helsinki, the International Conference on Harmonization (ICH) Good Clinical Practice (GCP) Guideline, and Federal Law № 323-FZ “On Basics of Health Protection of Citizens in the Russian Federation” of 21 November 2011. Informed consent for the study was provided by all participants.

Received: 2022-04-14 Accepted: 2022-04-28 Published online: 2022-05-17
|
  1. Chiu-Lin Wang, Yi-Yin liu, Chin-Hu Wu, Chun-Yu Wang, ChunHung Wang, Cheng-Yu Long. Impact of COVID-19 on Pregnancy. International Journal of Medical Sciences. 2021; 18 (3): 763–7. DOI: 10.7150/ijms.49923.
  2. Schwartz DA, Graham AL. Potential Maternal and Infant Outcomes from (Wuhan) Coronavirus 2019-nCoV Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections. Viruses. 2020; 12 (4): 194.
  3. Zaigham M, Andersson O. Maternal and perinatal outcomes with COVID–19:A systematic review of 108 pregnancies. Acta Obstet Gynecol Scand. 2020; 99 (7): 823–9.
  4. Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet. 2020; 395 (10226): 809–15.
  5. Sukhikh G, Petrova U, Prikhodko A, Starodubtseva N, Chingin K, Chen H, et al. Vertical Transmission of SARS-CoV-2 in Second Trimester Associated with Severe Neonatal Pathology. Viruses. 2021; 13 (3). DOI:10.3390/v13030447.
  6. Ellington S, Strid P, Tong VT, Woodworth K, Galang RR, Zambrano LD, et al. Characteristics of women of reproductive age with laboratory-confirmed SARS-COV-2 infection by pregnancy status — United States, January 22-June 7, 2020. Morb Mortal Wkly Rep. 2020; 69 (25): 769–5.
  7. Vivanti AJ, Vauloup-Fellous C, Prevot S, Zupan V, Suffee C, Do Cao J, et al. Transplacental transmission of SARS-CoV-2 infection. Nat Commun. 2020; 11 (1). DOI: 10.1038/s4146702017436-6.
  8. Shen B, Yi X, Sun Y, Bi X, Du J, Zhang C, et al. Proteomic and Metabolomic Characterization of COVID-19 Patient Sera. Cell. 2020; 182 (1): 59–72.
  9. McGarrah RW, Crown SB, Zhang G, Shah SH, M.H.S., Newgard CB. Cardiovascular Metabolomics. Circ Res. 2018; 122 (9): 1238–58. DOI: 10.1161/CIRCRESAHA.117.311002.
  10. Banoei MM, Vogel HJ, Weljie AM, Kumar A, Yende S, Angus DC, et al. Plasma metabolomics for the diagnosis and prognosis of H1N1 influenza pneumonia. 2017; 1–15.
  11. Inoue S, Ikeda H. Differences in plasma amino acid levels in patients with and without bacterial infection during the early stage of acute exacerbation of COPD. Int J COPD. 2019; 14: 575–83.
  12. Moat SJ, George RS, Carling RS. Use of Dried Blood Spot Specimens to Monitor Patients with Inherited Metabolic Disorders. Int J Neonatal Screen. 2020; 6 (2): 1–17.
  13. Páez-Franco JC, Torres-Ruiz J, Sosa-Hernández VA, CervantesDíaz R, Romero-Ramírez S, Pérez-Fragoso A, et al. Metabolomics analysis reveals a modified amino acid metabolism that correlates with altered oxygen homeostasis in COVID-19 patients. Sci Rep. 2021; 11 (1). DOI: 10.1038/s41598-021-85788-0.
  14. Rees CA, Rostad CA, Mantus G, Anderson EJ, Chahroudi A, Jaggi P. Altered amino acid profile in patients with SARS-CoV-2 infection. 2021; 118 (25): 4–6.
  15. Hirschel J, Vogel M, Baber R, Garten A, Beuchel C, Dietz Y, et al. Relation of whole blood amino acid and acylcarnitine metabolome to age, sex, BMI, puberty, and metabolic markers in children and adolescents. Metabolites. 2020; 10 (4). DOI: 10.3390/ metabo10040149.
  16. Lomova NA, Chagovets VV, Dolgopolova EL, Novoselova AV, Petrova UL, Shmakov RG, et al. Changes in amino acid profile of cord blood plasma and amniotic fluid of mothers with COVID-19. Bulletin of Russian State Medical University. 2021; (3): 12–22. DOI: 10.24075/BRSMU.2021.032
  17. Diorio C, McNerney KO, Lambert M, Paessler M, Anderson EM, Henrickson SE, et al. Evidence of thrombotic microangiopathy in children with SARS-CoV-2 across the spectrum of clinical presentations. Blood Adv. 2020; 4 (23): 6051–63.
  18. Tay MZ, Poh CM, Rénia L, MacAry PA, Ng LFP. The trinity of COVID-19: immunity, inflammation and intervention. Nature Reviews Immunology. 2020; 20 (6): 363–74.
  19. Gambardella J, Khondkar W, Morelli MB, Wang X, Santulli G, Trimarco V. Arginine and endothelial function. Biomedicines. 2020; 8 (8): 277.
  20. Rodríguez PC, Ochoa AC. Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: Mechanisms and therapeutic perspectives. Immunological Reviews. 2008; 222 (1): 180–91.
  21. Morris CR, Hamilton-Reeves J, Martindale RG, Sarav M, Ochoa Gautier JB. Acquired Amino Acid Deficiencies: A Focus on Arginine and Glutamine. In: Nutrition in Clinical Practice. SAGE Publications Inc., 2017; 30S–47S.
  22. IKEDA H. Plasma amino acid levels in individuals with bacterial pneumonia and healthy controls. 2020; 1–17.
  23. Ware LB, Magarik JA, Wickersham N, Cunningham G, Rice TW, Christman BW, et al. Low plasma citrulline levels are associated with acute respiratory distress syndrome in patients with severe sepsis. Crit Care. 2013; 17 (1): 1–8.
  24. Morris SM Jr. Arginine: beyond protein. Am J Clin Nutr. 2006; 83: 508S–12S.
  25. Schimke RT. Repression of enzymes of arginine biosynthesis in mammalian tissue culture. Biochim Biophys Acta. 1962; 62: 599–601.
  26. Jackson MJ, Allen SJ, Beaudet AL, O'Brien WE. Metabolite regulation of argininosuccinate synthetase in cultured human cells. J Biol Chem. 1988; 263: 16388–94.
  27. Lee J, Ryu H, Ferrante RJ, Morris SM Jr, Ratan RR. Translational control of inducible nitric oxide synthase expression by arginine can explain the arginine paradox. Proc Natl Acad Sci USA. 2003; 100: 4843–8.
  28. Taheri F, Ochoa JB, Faghiri Z, Culotta K, Park HJ, Lan MS, et al. L-Arginine regulates the expression of the T-cell receptor zeta chain (CD3zeta) in Jurkat cells. Clin Cancer Res. 2001; 7: 958s–65s.
  29. Fernandez J, Lopez AB, Wang C, Mishra R, Zhou L, Yaman I, et al. Transcriptional control of the arginine/lysine transporter, cat-1, by physiological stress. J Biol Chem. 2003; 278: 50000–9.
  30. Cheng J, Wang F, Yu DF, Wu PF, Chen JG. The cytotoxic mechanism of malondialdehyde and protective effect of carnosine via protein cross-linking/mitochondrial dysfunction/reactive oxygen species/MAPK pathway in neurons. European Journal of Pharmacology. 2011; 650, 184–94.